Aditxt (ADTX) Non-cash Items (2023 - 2025)

Aditxt (ADTX) recorded quarterly Non-cash Items of $181227.0 in Q4 2025, up 329403.64% quarter-over-quarter from $55.0 in Q3 2025, and up 307064.41% on a YoY basis from N/an in Q4 2024.

Aditxt (ADTX) Non-cash Items (2023 - 2025) Analysis & Trends

Aditxt's Non-cash Items history runs 3 years deep, the most recent figure standing at $181227.0 for Q4 2025.

  • In Q4 2025, Non-cash Items rose 307064.41% year-over-year to $181227.0; the TTM figure through Dec 2025 stood at $181227.0 (up 307064.41% YoY), while the FY2025 annual figure was $181227.0, up 307064.41% from the prior year.
  • Non-cash Items was $181227.0 for Q4 2025 at Aditxt, up from $55.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $10.7 million in Q2 2024 to a low of $55.0 in Q3 2025.
  • Historically, Non-cash Items has averaged $2.4 million across 3 years, with a median of $181227.0 in 2025.
  • Biggest YoY gain for Non-cash Items was 307064.41% in 2025; the steepest drop was 100.0% in 2025.
  • A 3-year view of Non-cash Items shows it stood at $45572.0 in 2023, then slumped by 99.87% to $59.0 in 2024, then surged by 307064.41% to $181227.0 in 2025.
  • The last three Non-cash Items figures came in at $181227.0 (Q4 2025), $55.0 (Q3 2025), and $181227.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00

Historic Data

Download Data
DateValue
Dec 31, 2025 181,227.00
Dec 31, 2025 181,227.00
Sep 30, 2025 55.00
Sep 30, 2025 55.00
Jun 30, 2025 181,227.00
Jun 30, 2025 181,227.00
Mar 31, 2025 181,227.00
Mar 31, 2025 181,227.00
Dec 31, 2024 59.00
Dec 31, 2024 59.00
Sep 30, 2024 10.65 Mn
Sep 30, 2024 10.65 Mn
Jun 30, 2024 10.65 Mn
Jun 30, 2024 10.65 Mn
Mar 31, 2024 45,572.00
Mar 31, 2024 45,572.00
Dec 31, 2023 45,572.00
Dec 31, 2023 45,572.00